In December 2017, CHIL completed its first export of diagnostic solutions to Sri Lanka, marking a strategic expansion into the South Asian market. This milestone highlighted the company’s commitment to providing high-quality diagnostics to new regions and reinforced its growing global presence. Building on prior international ventures, the Sri Lanka launch paved the way for continued outreach across emerging healthcare markets.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.